Adial Pharmaceuticals, Inc. (ADIL) vs Cytosorbents Corporation (CTSO)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and Cytosorbents Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CTSO
Cytosorbents Corporation
$3.97HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADIL vs CTSO
growth of $100 · dividends reinvested · last 8yADIL -99.8% (-54.9%/yr)CTSO -98.4% (-40.3%/yr)CTSO compounded faster over this window
Log scale — wide-divergence pair
ADIL CTSO
ADIL vs CTSO: by the numbers
- •CTSO is the larger company ($12M vs $11M market cap).
- •Both run net losses; ADIL's is the smaller (0.00% vs -48.94% net margin).
Metrics side by side
Valuation
| Metric | ADIL | CTSO |
|---|---|---|
| P/S ratio | N/A | 0.33 |
Profitability
| Metric | ADIL | CTSO |
|---|---|---|
| Gross margin | 0.00% | 71.61% |
| Operating margin | 0.00% | -33.37% |
| Net margin | 0.00% | -48.94% |
| ROE | -37052.06% | N/A |
| ROIC | -240.64% | -43.31% |
Growth (annualized)
| Metric | ADIL | CTSO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -3.17% |
| Total return CAGR (5Y) | -71.86% | -52.26% |
Frequently asked
- How have ADIL and CTSO total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and CTSO delivered -52.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.